ITMCTR2000002940RecruitingPhase 1
Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to — (—)
- Sex
- All
Inclusion Criteria
- •1) Comply with the diagnostic criteria for pneumonia caused by novel coronavirus infection in the Diagnosis and Treatment Program for pneumonia caused by novel coronavirus infection (Trial Version 4);
- •2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.
Exclusion Criteria
- •1) Patients with particularly severe pneumonia caused by novel coronavirus infection.
- •2) Patients whose initial onset time exceeds 5 days.
- •3) Patients with severe primary respiratory disease.
- •4) It is difficult to administer to patients by oral or nasal feeding.
- •5) Pregnant women, as well as patients with other malignancies such as malignant tumors, mental illnesses, and patients who are not considered suitable for study.
Investigators
Similar Trials
Recruiting
Phase 1
Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19)COVID-19ITMCTR2000003347Department of Pulmonology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Recruiting
Not Applicable
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000002997The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Recruiting
Phase 1
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)novel coronavirus pneumonia (COVID-19)ITMCTR2000003064Affiliated Hospital of Changchun University of traditional Chinese Medicine
Not yet recruiting
Phase 1
A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: A study protocol for a multicenter, randomized controlled trailGastric CancerITMCTR1900002830Jiangsu Province Hospital of Chinese Medicine
Not yet recruiting
Phase 1
A Prospective Study of Traditional Chinese Medicine Prevention and Treatment Schemes for Undifferentiated Connective Tissue DiseaseITMCTR2200005775ZHEJIANG CHINESE MEDICAL UNIVERSITY
